DLX6 and liver dysplastic nodule: Clinical trials have documented a marked elevation of lncRNA-DLX6-AS1 in renal biopsies from patients with DN, demonstrating a quantitative correlation between transcript abundance and urinary albumin–creatinine ratio (uACR) progression, thereby implicating DLX6-AS1 in DN progression (83).